APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Osimertinib Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Osimertinib Drugs Market Analysis and Forecast 2026-2032

Report ID 17402078022 January 2026196 pages

Choose your research edition.

Industry ResearchOsimertinib Drugs Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Osimertinib Drugs Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Osimertinib Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osimertinib Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Osimertinib Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Osimertinib Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Osimertinib Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Osimertinib Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Osimertinib Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Osimertinib Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Osimertinib Drugs include AstraZeneca. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Osimertinib Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Osimertinib Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Osimertinib Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Osimertinib Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Osimertinib Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Osimertinib Drugs sales, projected growth trends, production technology, application and end-user industry.

Osimertinib Drugs Segment by Company

AstraZeneca

Osimertinib Drugs Segment by Type

40mg

80mg

Osimertinib Drugs Segment by Application

Hospital

Drugs Store

Osimertinib Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osimertinib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osimertinib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osimertinib Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Osimertinib Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Osimertinib Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Osimertinib Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Osimertinib Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 40mg Major Manufacturers Table 3. 80mg Major Manufacturers Table 4. Global Osimertinib Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Drugs Store Major Manufacturers Table 7. Osimertinib Drugs Industry Trends Table 8. Osimertinib Drugs Industry Drivers Table 9. Osimertinib Drugs Industry Opportunities and Challenges Table 10. Osimertinib Drugs Industry Restraints Table 11. Global Osimertinib Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Osimertinib Drugs Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Osimertinib Drugs Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Osimertinib Drugs Revenue Market Share by Region (2021-2026) Table 15. Global Osimertinib Drugs Revenue Market Share by Region (2027-2032) Table 16. Global Osimertinib Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 17. Global Osimertinib Drugs Sales by Region (2021-2026) & (Units) Table 18. Global Osimertinib Drugs Sales by Region (2027-2032) & (Units) Table 19. Global Osimertinib Drugs Sales Market Share by Region (2021-2026) Table 20. Global Osimertinib Drugs Sales Market Share by Region (2027-2032) Table 21. Global Osimertinib Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Osimertinib Drugs Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Osimertinib Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Osimertinib Drugs Sales Market Share by Manufacturers (2021-2026) Table 25. Global Osimertinib Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Osimertinib Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Osimertinib Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Osimertinib Drugs Manufacturers, Product Type & Application Table 29. Global Osimertinib Drugs Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Osimertinib Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Osimertinib Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Osimertinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Osimertinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Osimertinib Drugs Revenue Market Share by Type (2021-2026) Table 36. Global Osimertinib Drugs Revenue Market Share by Type (2027-2032) Table 37. Global Osimertinib Drugs Sales by Type 2021 VS 2025 VS 2032 (Units) Table 38. Global Osimertinib Drugs Sales by Type (2021-2026) & (Units) Table 39. Global Osimertinib Drugs Sales by Type (2027-2032) & (Units) Table 40. Global Osimertinib Drugs Sales Market Share by Type (2021-2026) Table 41. Global Osimertinib Drugs Sales Market Share by Type (2027-2032) Table 42. Global Osimertinib Drugs Price by Type (2021-2026) & (US$/Unit) Table 43. Global Osimertinib Drugs Price by Type (2027-2032) & (US$/Unit) Table 44. Global Osimertinib Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Osimertinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Osimertinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Osimertinib Drugs Revenue Market Share by Application (2021-2026) Table 48. Global Osimertinib Drugs Revenue Market Share by Application (2027-2032) Table 49. Global Osimertinib Drugs Sales by Application 2021 VS 2025 VS 2032 (Units) Table 50. Global Osimertinib Drugs Sales by Application (2021-2026) & (Units) Table 51. Global Osimertinib Drugs Sales by Application (2027-2032) & (Units) Table 52. Global Osimertinib Drugs Sales Market Share by Application (2021-2026) Table 53. Global Osimertinib Drugs Sales Market Share by Application (2027-2032) Table 54. Global Osimertinib Drugs Price by Application (2021-2026) & (US$/Unit) Table 55. Global Osimertinib Drugs Price by Application (2027-2032) & (US$/Unit) Table 56. AstraZeneca Company Information Table 57. AstraZeneca Business Overview Table 58. AstraZeneca Osimertinib Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. AstraZeneca Osimertinib Drugs Product Portfolio Table 60. AstraZeneca Recent Development Table 61. North America Osimertinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 62. North America Osimertinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 63. North America Osimertinib Drugs Sales by Type (2021-2026) & (Units) Table 64. North America Osimertinib Drugs Sales by Type (2027-2032) & (Units) Table 65. North America Osimertinib Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 66. North America Osimertinib Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 67. North America Osimertinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 68. North America Osimertinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 69. North America Osimertinib Drugs Sales by Application (2021-2026) & (Units) Table 70. North America Osimertinib Drugs Sales by Application (2027-2032) & (Units) Table 71. North America Osimertinib Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 72. North America Osimertinib Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 73. North America Osimertinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Osimertinib Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 75. North America Osimertinib Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 76. North America Osimertinib Drugs Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 77. North America Osimertinib Drugs Sales by Country (2021-2026) & (Units) Table 78. North America Osimertinib Drugs Sales by Country (2027-2032) & (Units) Table 79. North America Osimertinib Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 80. North America Osimertinib Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 81. United States Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 82. Canada Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 83. Europe Osimertinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 84. Europe Osimertinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 85. Europe Osimertinib Drugs Sales by Type (2021-2026) & (Units) Table 86. Europe Osimertinib Drugs Sales by Type (2027-2032) & (Units) Table 87. Europe Osimertinib Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 88. Europe Osimertinib Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 89. Europe Osimertinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 90. Europe Osimertinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 91. Europe Osimertinib Drugs Sales by Application (2021-2026) & (Units) Table 92. Europe Osimertinib Drugs Sales by Application (2027-2032) & (Units) Table 93. Europe Osimertinib Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 94. Europe Osimertinib Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 95. Europe Osimertinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Osimertinib Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 97. Europe Osimertinib Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 98. Europe Osimertinib Drugs Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 99. Europe Osimertinib Drugs Sales by Country (2021-2026) & (Units) Table 100. Europe Osimertinib Drugs Sales by Country (2027-2032) & (Units) Table 101. Europe Osimertinib Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 102. Europe Osimertinib Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 103. Germany Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 104. France Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 105. U.K. Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 106. Italy Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 107. Netherlands Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 108. China Osimertinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 109. China Osimertinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 110. China Osimertinib Drugs Sales by Type (2021-2026) & (Units) Table 111. China Osimertinib Drugs Sales by Type (2027-2032) & (Units) Table 112. China Osimertinib Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 113. China Osimertinib Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 114. China Osimertinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 115. China Osimertinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 116. China Osimertinib Drugs Sales by Application (2021-2026) & (Units) Table 117. China Osimertinib Drugs Sales by Application (2027-2032) & (Units) Table 118. China Osimertinib Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 119. China Osimertinib Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 120. Asia Osimertinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia Osimertinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia Osimertinib Drugs Sales by Type (2021-2026) & (Units) Table 123. Asia Osimertinib Drugs Sales by Type (2027-2032) & (Units) Table 124. Asia Osimertinib Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 125. Asia Osimertinib Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 126. Asia Osimertinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 127. Asia Osimertinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Osimertinib Drugs Sales by Application (2021-2026) & (Units) Table 129. Asia Osimertinib Drugs Sales by Application (2027-2032) & (Units) Table 130. Asia Osimertinib Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 131. Asia Osimertinib Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Asia Osimertinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Osimertinib Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Asia Osimertinib Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Asia Osimertinib Drugs Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 136. Asia Osimertinib Drugs Sales by Country (2021-2026) & (Units) Table 137. Asia Osimertinib Drugs Sales by Country (2027-2032) & (Units) Table 138. Asia Osimertinib Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 139. Asia Osimertinib Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 140. Japan Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 141. South Korea Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 142. India Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 143. Australia Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 144. China Taiwan Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 145. Southeast Asia Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 146. SAMEA Osimertinib Drugs Revenue by Type (2021-2026) & (US$ Million) Table 147. SAMEA Osimertinib Drugs Revenue by Type (2027-2032) & (US$ Million) Table 148. SAMEA Osimertinib Drugs Sales by Type (2021-2026) & (Units) Table 149. SAMEA Osimertinib Drugs Sales by Type (2027-2032) & (Units) Table 150. SAMEA Osimertinib Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 151. SAMEA Osimertinib Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 152. SAMEA Osimertinib Drugs Revenue by Application (2021-2026) & (US$ Million) Table 153. SAMEA Osimertinib Drugs Revenue by Application (2027-2032) & (US$ Million) Table 154. SAMEA Osimertinib Drugs Sales by Application (2021-2026) & (Units) Table 155. SAMEA Osimertinib Drugs Sales by Application (2027-2032) & (Units) Table 156. SAMEA Osimertinib Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 157. SAMEA Osimertinib Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 158. SAMEA Osimertinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. SAMEA Osimertinib Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. SAMEA Osimertinib Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. SAMEA Osimertinib Drugs Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 162. SAMEA Osimertinib Drugs Sales by Country (2021-2026) & (Units) Table 163. SAMEA Osimertinib Drugs Sales by Country (2027-2032) & (Units) Table 164. SAMEA Osimertinib Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 165. SAMEA Osimertinib Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Brazil Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 167. Argentina Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 168. Chile Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 169. Colombia Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 170. Peru Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 171. Saudi Arabia Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 172. Israel Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 173. UAE Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 174. Turkey Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 175. Iran Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 176. Egypt Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Osimertinib Drugs Distributors List Table 180. Osimertinib Drugs Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Osimertinib Drugs Image Figure 2. Global Osimertinib Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Osimertinib Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. 40mg Image Figure 5. 80mg Image Figure 6. Global Osimertinib Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Osimertinib Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drugs Store Image Figure 10. Global Osimertinib Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Osimertinib Drugs Revenue (2021-2032) & (US$ Million) Figure 12. Global Osimertinib Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Osimertinib Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Osimertinib Drugs Revenue Market Share by Region (2021-2032) Figure 15. Global Osimertinib Drugs Sales (2021-2032) & (Units) Figure 16. Global Osimertinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 17. Global Osimertinib Drugs Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Osimertinib Drugs Sales YoY (2021-2032) & (Units) Figure 19. Europe Osimertinib Drugs Sales YoY (2021-2032) & (Units) Figure 20. China Osimertinib Drugs Sales YoY (2021-2032) & (Units) Figure 21. Asia (Excluding China) Osimertinib Drugs Sales YoY (2021-2032) & (Units) Figure 22. South America, Middle East and Africa Osimertinib Drugs Sales YoY (2021-2032) & (Units) Figure 23. Global Osimertinib Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Osimertinib Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Osimertinib Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Osimertinib Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Osimertinib Drugs Revenue Market Share by Type (2021-2032) Figure 29. Global Osimertinib Drugs Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 30. Global Osimertinib Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Osimertinib Drugs Sales Market Share by Type (2021-2032) Figure 32. Global Osimertinib Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Osimertinib Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Osimertinib Drugs Revenue Market Share by Application (2021-2032) Figure 35. Global Osimertinib Drugs Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 36. Global Osimertinib Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Osimertinib Drugs Sales Market Share by Application (2021-2032) Figure 38. North America Osimertinib Drugs Revenue Share by Type (2021-2032) Figure 39. North America Osimertinib Drugs Sales Share by Type (2021-2032) Figure 40. North America Osimertinib Drugs Revenue Share by Application (2021-2032) Figure 41. North America Osimertinib Drugs Sales Share by Application (2021-2032) Figure 42. North America Osimertinib Drugs Revenue Share by Country (2021-2032) Figure 43. North America Osimertinib Drugs Sales Share by Country (2021-2032) Figure 44. Europe Osimertinib Drugs Revenue Share by Type (2021-2032) Figure 45. Europe Osimertinib Drugs Sales Share by Type (2021-2032) Figure 46. Europe Osimertinib Drugs Revenue Share by Application (2021-2032) Figure 47. Europe Osimertinib Drugs Sales Share by Application (2021-2032) Figure 48. Europe Osimertinib Drugs Revenue Share by Country (2021-2032) Figure 49. Europe Osimertinib Drugs Sales Share by Country (2021-2032) Figure 50. China Osimertinib Drugs Revenue Share by Type (2021-2032) Figure 51. China Osimertinib Drugs Sales Share by Type (2021-2032) Figure 52. China Osimertinib Drugs Revenue Share by Application (2021-2032) Figure 53. China Osimertinib Drugs Sales Share by Application (2021-2032) Figure 54. Asia Osimertinib Drugs Revenue Share by Type (2021-2032) Figure 55. Asia Osimertinib Drugs Sales Share by Type (2021-2032) Figure 56. Asia Osimertinib Drugs Revenue Share by Application (2021-2032) Figure 57. Asia Osimertinib Drugs Sales Share by Application (2021-2032) Figure 58. Asia Osimertinib Drugs Revenue Share by Country (2021-2032) Figure 59. Asia Osimertinib Drugs Sales Share by Country (2021-2032) Figure 60. SAMEA Osimertinib Drugs Revenue Share by Type (2021-2032) Figure 61. SAMEA Osimertinib Drugs Sales Share by Type (2021-2032) Figure 62. SAMEA Osimertinib Drugs Revenue Share by Application (2021-2032) Figure 63. SAMEA Osimertinib Drugs Sales Share by Application (2021-2032) Figure 64. SAMEA Osimertinib Drugs Revenue Share by Country (2021-2032) Figure 65. SAMEA Osimertinib Drugs Sales Share by Country (2021-2032) Figure 66. Osimertinib Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Osimertinib Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg
  • 80mg
Applications
  • Hospital
  • Drugs Store
Companies covered
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Osimertinib Drugs Market by Type
  3. 1.2.1 Global Osimertinib Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 40mg
  5. 1.2.3 80mg
  6. 1.3 Osimertinib Drugs Market by Application
  7. 1.3.1 Global Osimertinib Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drugs Store
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Osimertinib Drugs Market Dynamics
  1. 2.1 Osimertinib Drugs Industry Trends
  2. 2.2 Osimertinib Drugs Industry Drivers
  3. 2.3 Osimertinib Drugs Industry Opportunities and Challenges
  4. 2.4 Osimertinib Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Osimertinib Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Osimertinib Drugs Revenue by Region
  3. 3.2.1 Global Osimertinib Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Osimertinib Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Osimertinib Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Osimertinib Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Osimertinib Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Osimertinib Drugs Sales by Region
  9. 3.4.1 Global Osimertinib Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Osimertinib Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Osimertinib Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Osimertinib Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Osimertinib Drugs Revenue by Manufacturers
  2. 4.1.1 Global Osimertinib Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Osimertinib Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Osimertinib Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Osimertinib Drugs Sales by Manufacturers
  6. 4.2.1 Global Osimertinib Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Osimertinib Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Osimertinib Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Osimertinib Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Osimertinib Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Osimertinib Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Osimertinib Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Osimertinib Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Osimertinib Drugs Market CR5 and HHI
  16. 4.8.2 2025 Osimertinib Drugs Tier 1, Tier 2, and Tier 3
5 Osimertinib Drugs Market by Type
  1. 5.1 Global Osimertinib Drugs Revenue by Type
  2. 5.1.1 Global Osimertinib Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Osimertinib Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Osimertinib Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Osimertinib Drugs Sales by Type
  6. 5.2.1 Global Osimertinib Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Osimertinib Drugs Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Osimertinib Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Osimertinib Drugs Price by Type
6 Osimertinib Drugs Market by Application
  1. 6.1 Global Osimertinib Drugs Revenue by Application
  2. 6.1.1 Global Osimertinib Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Osimertinib Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Osimertinib Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Osimertinib Drugs Sales by Application
  6. 6.2.1 Global Osimertinib Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Osimertinib Drugs Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Osimertinib Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Osimertinib Drugs Price by Application
7 Company Profiles
  1. 7.1 AstraZeneca
  2. 7.1.1 AstraZeneca Company Information
  3. 7.1.2 AstraZeneca Business Overview
  4. 7.1.3 AstraZeneca Osimertinib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AstraZeneca Osimertinib Drugs Product Portfolio
  6. 7.1.5 AstraZeneca Recent Developments
8 North America
  1. 8.1 North America Osimertinib Drugs Market Size by Type
  2. 8.1.1 North America Osimertinib Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Osimertinib Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Osimertinib Drugs Price by Type (2021-2032)
  5. 8.2 North America Osimertinib Drugs Market Size by Application
  6. 8.2.1 North America Osimertinib Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Osimertinib Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Osimertinib Drugs Price by Application (2021-2032)
  9. 8.3 North America Osimertinib Drugs Market Size by Country
  10. 8.3.1 North America Osimertinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Osimertinib Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Osimertinib Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Osimertinib Drugs Market Size by Type
  2. 9.1.1 Europe Osimertinib Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Osimertinib Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Osimertinib Drugs Price by Type (2021-2032)
  5. 9.2 Europe Osimertinib Drugs Market Size by Application
  6. 9.2.1 Europe Osimertinib Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Osimertinib Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Osimertinib Drugs Price by Application (2021-2032)
  9. 9.3 Europe Osimertinib Drugs Market Size by Country
  10. 9.3.1 Europe Osimertinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Osimertinib Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Osimertinib Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Osimertinib Drugs Market Size by Type
  2. 10.1.1 China Osimertinib Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Osimertinib Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Osimertinib Drugs Price by Type (2021-2032)
  5. 10.2 China Osimertinib Drugs Market Size by Application
  6. 10.2.1 China Osimertinib Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Osimertinib Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Osimertinib Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Osimertinib Drugs Market Size by Type
  2. 11.1.1 Asia Osimertinib Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Osimertinib Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Osimertinib Drugs Price by Type (2021-2032)
  5. 11.2 Asia Osimertinib Drugs Market Size by Application
  6. 11.2.1 Asia Osimertinib Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Osimertinib Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Osimertinib Drugs Price by Application (2021-2032)
  9. 11.3 Asia Osimertinib Drugs Market Size by Country
  10. 11.3.1 Asia Osimertinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Osimertinib Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Osimertinib Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Osimertinib Drugs Market Size by Type
  2. 12.1.1 SAMEA Osimertinib Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Osimertinib Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Osimertinib Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Osimertinib Drugs Market Size by Application
  6. 12.2.1 SAMEA Osimertinib Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Osimertinib Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Osimertinib Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Osimertinib Drugs Market Size by Country
  10. 12.3.1 SAMEA Osimertinib Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Osimertinib Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Osimertinib Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Osimertinib Drugs Value Chain Analysis
  2. 13.1.1 Osimertinib Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Osimertinib Drugs Production Mode & Process
  6. 13.2 Osimertinib Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Osimertinib Drugs Distributors
  9. 13.2.3 Osimertinib Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst